Companies / Agios Pharmaceuticals, Inc. / Activity
Activity — Agios Pharmaceuticals, Inc.
106 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Foster-Cheek Kaye I Director | Exercise | Common stock | $0 | +3K +37.71% | 10,284 0.02% of shares | low |
| Jun 18, 2026 | Capello Jeffrey D Director | Exercise | Common stock | $0 | +3K +34.99% | 10,865 0.02% of shares | low |
| Jun 13, 2026 | Capello Jeffrey D Director | Exercise | Common stock | $0 | +2K +32.54% | 8,049 0.01% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Common stock | $0 | +5K +11.63% | 50,901 0.09% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Common stock | $0 | +4K +9.35% | 46,785 0.08% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Common stock | $0 | +6K +14.60% | 44,466 0.07% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Common stock | $0 | +2K +5.35% | 39,394 0.07% of shares | low |
| Dec 30, 2025 | Jones Cecilia Executive | Exercise | Common stock | $0 | +6K +17.48% | 40,326 0.07% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Common stock | $0 | +13K +8.26% | 170,466 0.29% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Common stock | $0 | +18K +12.18% | 165,733 0.28% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Common stock | $0 | +9K +5.94% | 151,603 0.25% of shares | low |
| Dec 30, 2025 | Goff Brian CEO | Exercise | Common stock | $0 | +13K +9.34% | 149,333 0.25% of shares | low |
| Dec 30, 2025 | Goff Brian CEO | Exercise | Common stock | $0 | +26K +20.67% | 149,056 0.25% of shares | low |
| Mar 5, 2026 | Viswanadhan Krishnan Executive | Exercise | Common stock | $0 | +8K | 8,100 0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Common stock | $0 | +4K +9.48% | 45,249 0.08% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Common stock | $0 | +4K +10.39% | 42,516 0.07% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Common stock | $0 | +6K +16.41% | 40,197 0.07% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Common stock | $0 | +4K +12.61% | 35,718 0.06% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Common stock | $0 | +4K +5.59% | 75,593 0.13% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Common stock | $0 | +6K +8.38% | 73,274 0.12% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Common stock | $0 | +4K +6.17% | 68,795 0.12% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Exercise | Common stock | $0 | +4K +10.32% | 42,778 0.07% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Exercise | Common stock | $0 | +6K +16.28% | 40,459 0.07% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Common stock | $0 | +3K +63.52% | 6,938 0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Common stock | $0 | +2K +97.22% | 4,970 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Common stock | $0 | +2K +249.20% | 3,293 <0.01% of shares | low |
| Jan 5, 2026 | Milanova Tsveta Executive | Exercise | Common stock | $0 | +8K +29.03% | 37,665 0.06% of shares | low |
| Dec 30, 2025 | Burns James William Executive | Exercise | Common stock | $0 | +6K +20.94% | 34,650 0.06% of shares | low |
| Dec 30, 2025 | Gheuens Sarah Executive | Exercise | Common stock | $0 | +6K +9.72% | 67,727 0.11% of shares | low |
| Dec 30, 2025 | Milanova Tsveta Executive | Exercise | Common stock | $0 | +6K +22.97% | 32,122 0.05% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Sell | Common stock | $17.2K | -594 -1.51% | 38,800 0.06% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Sell | Common stock | $20.2K | -698 -21.20% | 2,595 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Sell | Common stock | $21.1K | -727 -14.63% | 4,243 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Sell | Common stock | $23.1K | -798 -11.50% | 6,140 0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Sell | Common stock | $33.7K | -1K -2.57% | 44,086 0.07% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Sell | Common stock | $34.4K | -1K -2.54% | 45,598 0.08% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Sell | Common stock | $34.4K | -1K -2.79% | 41,329 0.07% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Sell | Common stock | $34.4K | -1K -3.32% | 34,531 0.06% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Sell | Common stock | $34.4K | -1K -1.57% | 74,406 0.12% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Sell | Common stock | $34.4K | -1K -1.73% | 67,608 0.11% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Sell | Common stock | $34.4K | -1K -2.77% | 41,591 0.07% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Sell | Common stock | $45.6K | -2K -3.09% | 49,328 0.08% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Sell | Common stock | $48.7K | -2K -3.78% | 42,785 0.07% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Sell | Common stock | $48.7K | -2K -4.18% | 38,516 0.06% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Sell | Common stock | $48.7K | -2K -2.29% | 71,593 0.12% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Sell | Common stock | $48.7K | -2K -4.15% | 38,778 0.06% of shares | low |
| Jan 5, 2026 | Milanova Tsveta Executive | Sell | Common stock | $77.6K | -3K -7.63% | 34,793 0.06% of shares | low |
| Dec 30, 2025 | Jones Cecilia Executive | Sell | Common stock | $79.4K | -3K -7.27% | 37,394 0.06% of shares | low |
| Dec 30, 2025 | Burns James William Executive | Sell | Common stock | $79.4K | -3K -8.46% | 31,718 0.05% of shares | low |
| Dec 30, 2025 | Gheuens Sarah Executive | Sell | Common stock | $79.4K | -3K -4.33% | 64,795 0.11% of shares | low |